Articles

Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
Haematologica Early view Nov 30, 2023 https://doi.org/10.3324/haematol.2023.284453